Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
5.96
-0.43 (-6.73%)
Sep 3, 2025, 11:55 AM - Market open
Clene Revenue
Clene had revenue of $27.00K in the quarter ending June 30, 2025, a decrease of -70.33%. This brings the company's revenue in the last twelve months to $286.00K, down -35.29% year-over-year. In the year 2024, Clene had annual revenue of $342.00K, down -47.71%.
Revenue (ttm)
$286.00K
Revenue Growth
-35.29%
P/S Ratio
186.14
Revenue / Employee
$3,763
Employees
76
Market Cap
59.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 342.00K | -312.00K | -47.71% |
| Dec 31, 2023 | 654.00K | 181.00K | 38.27% |
| Dec 31, 2022 | 473.00K | -250.00K | -34.58% |
| Dec 31, 2021 | 723.00K | 517.00K | 250.97% |
| Dec 31, 2020 | 206.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Walmart | 693.15B |
| Costco Wholesale | 268.78B |
| PepsiCo | 91.75B |
| The Procter & Gamble Company | 84.28B |
| Unilever | 70.19B |
| Anheuser-Busch InBev | 58.52B |
| The Coca-Cola Company | 47.06B |
| Philip Morris International | 39.06B |
CLNN News
- 1 day ago - Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 20 days ago - Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 21 days ago - Clene to Present at the Emerging Growth Conference - GlobeNewsWire
- 4 weeks ago - Clene to Present at the Canaccord 45th Annual Growth Conference - GlobeNewsWire
- 2 months ago - Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings - GlobeNewsWire
- 3 months ago - Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 - Accesswire
- 4 months ago - Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 5 months ago - Clene to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewsWire